Insider Trading & Ownership of James C. Momtazee

Location
Menlo Park, CA
Summary
The estimated net worth of James C. Momtazee is at least $6,152,945 dollars as of 21 Apr 2026. James C. Momtazee is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $3.12M. James C. Momtazee is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $3.03M.
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for James C Momtazee
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow James C. Momtazee and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • James C. Momtazee has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $6,152,945.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BridgeBio Pharma, Inc. ($3,122,427).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of James C. Momtazee

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Director $3,122,427 20 Jun 2025
ROIV Roivant Sciences Ltd. Director $3,030,518 17 Apr 2026
MAAC Montes Archimedes Acquisition Corp Chief Executive Officer, Director, 10%+ Owner 30 Sep 2021
PRAH PRA Health Sciences, Inc. Director 01 Jul 2021

Insider Transactions Reported by James C. Momtazee:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .